Self-triage and clinic waiting times.

randomised non-inferiority trial and meta-analysis. Lancet 2010; 375: 555–562. 4 Creinin MD, Schlaff W, Archer DF, Wan L, Frezieres R, Thomas M, et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 2006; 108: 1089–1097. 5 von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bártfai G, et al; WHO Research Group on Postovulatory Methods of Fertility Regulation. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002; 360: 1803–1810. 6 Cameron S, Glasier A, Fine P, Mathé H, Gainer E. Ulipristal acetate compared to levonorgestrel for emergency contraception within five days of unprotected intercourse: a randomized controlled trial. Abstract presented at the 8th Congress of the European Society of Gynecology, Rome, Italy, 10–13 September 2009. 7 Cheng L, Gülmezoglu AM, Piaggio G, Ezcurra E, Van Look PF. Interventions for emergency contraception. Cochrane Database Syst Rev 2008; 2: CD001324. 8 Cameron S, Glasier A . The need to take a ‘new look’ at emergency contraception. J Fam Plann Reprod Health Care 2010; 36: 3–4. 9 HRA Pharma UK Ltd. ellaOne 30 mg: Summary of Product Characteristics. 2009. http://emc.medicines. org.uk/medicine/22280/SPC/el laOne+30+mg/ [Accessed 4 February 2010]. 10 Croxatto HB, Brache V, Cochon L, Jesam C, Salvatierra AM, Levy D, et al. The effects of immediate pre-ovulatory administration of 30 mg ulipristal acetate on follicular rupture. Abstract presented at the 8th Congress of the European Society of Gynecology, Rome, Italy, 10–13 September 2009. 11 Rickert VI, Tiezzi L, Lipshutz J, León J, Vaughan RD, Westhoff C. Depo now: preventing unintended pregnancies among adolescents and young adults. J Adolesc Health 2007; 40: 22–28.